A phase I study of the safety and immunogenicity of a West Nile virus recombinant DNA plasmid vaccine, VRC-WNVDNA017-00 VP, in healthy adult volunteers
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs West Nile virus vaccine (Primary)
- Indications West Nile virus infections
- Focus Adverse reactions
- 16 Jan 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 05 Nov 2005 New trial record.